| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_384d7bc5ff6035f03660f56fbfa33947
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdf2b9a5092086adfbf5f35201584725 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2017-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eff54544e3ab1b35f9d9e244b40c1ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e68c31dcfaeaa5b21715aebaef3a49f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2b731844bdbc8d4638ddbcf48c9e47e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e64fbe41e3d3b2516716b6152eb11c |
| publicationDate |
2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018085360-A1 |
| titleOfInvention |
Centrally acting acetylcholinesterase inhibitors for the prevention and/or treatment of chemically induced neuropathies and the symptoms thereof, and corresponding compositions, uses, methods and kit |
| abstract |
The invention relates to a composition for using in the treatment and/or prevention of chemically induced neuropathies, said composition comprising at least one reversible centrally acting acetylcholinesterase inhibitor. The invention also relates to the corresponding methods, uses and kit. |
| priorityDate |
2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |